M84.57 Pathological fracture in neoplastic disease, ankle and foot

Name of the Condition

• Pathological Fracture in Neoplastic Disease, Ankle and Foot (ICD-10-CM: M84.57)

Summary

This condition describes a bone fracture occurring due to underlying neoplastic (cancerous) disease, specifically involving the ankle and foot. The fracture results from weakened bone structure caused by the presence of cancer, rather than direct trauma. It is a complication of malignancy affecting the ankle and foot's bone integrity, which may involve primary bone tumors or metastatic spread to these regions.

Causes

Pathological fractures in neoplastic disease arise when cancerous growths infiltrate or destroy bone tissue in the ankle and foot, compromising their structural strength. Primary bone cancers (e.g., osteosarcoma) or metastatic tumors (e.g., from breast, lung, or prostate cancer) can erode bone in these areas, leading to spontaneous or minimal-force fractures. Tumor-induced bone destruction or treatment-related effects (e.g., radiation therapy) may also contribute to the weakened bone.

Risk Factors

• History of cancer, particularly with known bone metastasis to the ankle or foot.
• Advanced-stage malignancies with skeletal involvement.
• Tumors that preferentially affect bone (e.g., multiple myeloma).
• Prior radiation therapy to ankle or foot sites.
• Systemic therapies that weaken bone (e.g., certain chemotherapies).

Symptoms

• Sudden onset of pain at the fracture site, often without obvious injury.
• Swelling, bruising, or visible deformity in the affected area.
• Difficulty bearing weight or limited mobility of the ankle or foot.
• Possible instability or abnormal positioning of the affected limb.

Diagnosis

Diagnosis involves a combination of clinical evaluation, imaging studies, and correlation with the patient's cancer history. X-rays or CT scans may reveal a fracture with underlying bone lesions or tumor involvement. MRI can assess soft tissue and bone marrow changes. Biopsy or prior cancer documentation may confirm neoplastic disease as the cause. Laboratory tests (e.g., tumor markers) may support the diagnosis but are not definitive alone.

Treatment Options

Treatment focuses on stabilizing the fracture, managing pain, and addressing the underlying cancer. Options may include immobilization (casting, bracing), surgical fixation (plates, screws), or bone-strengthening therapies (bisphosphonates, denosumab). Oncologic treatment (chemotherapy, radiation) targets the primary or metastatic disease. Pain management and rehabilitation support recovery and function.

Prognosis and Follow-Up

Prognosis depends on the extent of bone damage, cancer type, and treatment response. Fractures in weight-bearing areas (ankle, foot) may require prolonged immobilization or surgery. Regular follow-up monitors fracture healing, cancer progression, and functional recovery. Long-term surveillance assesses for recurrent fractures or metastatic spread.

Complications

• Delayed or nonunion of the fracture due to compromised bone healing.
• Infection, especially with surgical intervention.
• Chronic pain or reduced mobility affecting daily function.
• Progression of underlying cancer, potentially worsening bone integrity.
• Nerve or vascular damage from the fracture or treatment.

Lifestyle & Prevention

• Avoid high-impact activities that stress the ankle or foot.
• Use supportive footwear or orthotics to reduce strain.
• Maintain bone health through nutrition (calcium, vitamin D) and safe exercise.
• Follow oncologic treatment plans to control cancer-related bone damage.
• Report new or worsening pain promptly to healthcare providers.

When to Seek Professional Help

Seek immediate care for sudden, severe pain, visible deformity, or inability to bear weight. Contact a provider for persistent pain, swelling, or signs of infection (redness, fever) after a fracture. Regular oncologic follow-up is essential to monitor for recurrence or new fractures.

Tips for Medical Coders

Document the fracture site (ankle or foot) and confirm the underlying neoplastic disease. Include clinical details (e.g., imaging findings, cancer history) to support the diagnosis. Ensure the code aligns with the specific anatomical location and neoplastic cause, avoiding unspecified site codes when location is known.